President's Commission on Combating Drug Addiction and the Opioid Crisis, Final Report   [open pdf - 3MB]

From the conclusion: "The goals of the recommendations included in this report are to promote prevention of all drug use with effective education campaigns and restrictions in supply of illicit and misused drugs. To achieve supply reduction, we recommend shaping prescribing practices by improved medical education, by alternatives to pain management, as appropriate, by enhancing physician awareness of high risk patients though substance use, mental, and medical screenings and interrogation of PDMPs [Prescription Drug Monitoring Program], insurance company oversight, and by interdiction of deadly opioids. Treatment and overdose rescue are both distinct and inextricably linked efforts. Overdose rescue procedures need to be opportunistic and include access to trained personnel, to medications, and to treatment services. [...] Treatment services need to be improved, foremost by developing thoughtful national evidence-based standards of care, record-keeping, and long-term support. In view of the need, expansion of services is imperative and so are surmounting barriers - to medications, limited healthcare workforce, to insurance reimbursement - and ensuring high-quality care and long-term recovery support services. The Commission strongly supports research and development of alternatives to opioids for pain management, treatment and rescue, and of modern medical devices essential to improving our responses. The Commission also strongly recommends real-time data analytics to inform our mission and accomplishments. Above all, each recommendation should have accountability built-in and be subjected to measurable goals, quantitative solutions, and measurable outcomes. The Federal Government now must develop a level of accountability that has not been imposed rigorously in the past."

Public Domain
Retrieved From:
White House: https://www.whitehouse.gov/
Media Type:
Help with citations
Listed on November 8, 2017 [Critical Releases]
Listed on Opioids [Featured Topic]